NEWSROOM

Press Releases
In the News
Logo & Resources Library

Recent News

News Update
LRA Spotlight on ACR Convergence 2024: Lupus Therapeutics-Supported Clinical Research and More
November 21, 2024
New ACR guidelines for advancing the management of lupus nephritis (LN). Novel approaches and promising data from early- to...
Press Release
News from ACR Convergence 2024
Lupus Therapeutics Statement on Phase 3 PHOENYCS GO Positive Data In Moderate-To-Severe Systemic Lupus
November 21, 2024
Lupus Therapeutics, the clinical research affiliate of the Lupus Research Alliance (LRA), is encouraged by the positive Phase 3...
News Update
News from ACR Convergence 2024
ACR Released a Summary of the 2024 ACR Guideline for the Screening, Treatment, and Management of Lupus Nephritis
November 18, 2024
The American College of Rheumatology (ACR) released a summary of the 2024 ACR Guideline for the Screening, Treatment, and...
Press Release
Announcing LRA-supported research studies at ACR
Lupus Research Alliance Announces Lupus Research Highlights at ACR Convergence 2024
November 4, 2024
Sixteen presentations of preclinical studies funded by the Lupus Research Alliance to advance understanding of lupus and potential treatment pathways,...
News Update
Gazyva® Shows Positive Results in Phase 3 Lupus Nephritis Trial
September 25, 2024
The Lupus Research Alliance (LRA) and clinical research affiliate Lupus Therapeutics (LT) are excited to share positive news of...
News Update
Investigational Treatment Dapirolizumab Pegol Shows Positive Results in Phase 3 Clinical Trial
September 24, 2024
Lupus Therapeutics, the clinical research affiliate of the Lupus Research Alliance, is proud to share positive topline results from...
News Update
Statement in Response to Recent Lupus Science and Medicine Publication
July 16, 2024
A study recently published in Lupus Science and Medicine showed that krill oil concentrate helped to increase Omega-3 deficiency...
News Update
On “Lupus Call to Action Day”, the Lupus Research Alliance and Lupus Therapeutics Amplify a Call for Equity and Inclusion
May 1, 2024
As part of Lupus Awareness Month, May 1 has been declared “Lupus Call to Action Day” by the National...
News Update
Lupus Peer-to-Peer Early Education Program Expands
March 28, 2024
Lupus Therapeutics, the clinical research affiliate of the Lupus Research Alliance, has announced an innovative expansion of the highly...
Press Release
Lupus Therapeutics Announces Collaboration to Support the Evaluation of Non-Genetically Modified Cell-Based Therapy for Lupus Nephritis with Artiva Biotherapeutics
March 14, 2024
Lupus Therapeutics, the clinical research affiliate of the Lupus Research Alliance, announced a collaboration with Artiva Biotherapeutics, Inc. on...
News Update
Summary Highlights of Important Research Presented at ACR Convergence 2023
November 29, 2023
At the recent ACR Convergence 2023, the annual meeting of the American College of Rheumatology, important lupus clinical trial...
News Update
Positive One-Year Results of PALS Program Published in Prestigious Rheumatology Journal
October 27, 2023
Lupus Therapeutics, the clinical research affiliate of the Lupus Research Alliance, is proud to share that the successful results...